| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 747.28B | 727.49B | 617.71B | 502.20B | 458.23B | 471.06B |
| Gross Profit | 50.90B | 47.58B | 53.33B | 26.42B | 37.23B | 50.04B |
| EBITDA | 42.49B | 30.52B | 37.30B | 10.16B | 23.46B | 38.12B |
| Net Income | 14.14B | 12.46B | 17.88B | 684.00M | 10.75B | 20.99B |
Balance Sheet | ||||||
| Total Assets | 683.11B | 660.13B | 566.03B | 508.18B | 467.36B | 452.25B |
| Cash, Cash Equivalents and Short-Term Investments | 53.03B | 57.27B | 60.19B | 50.50B | 44.86B | 59.79B |
| Total Debt | 219.32B | 166.47B | 110.32B | 93.69B | 92.56B | 82.21B |
| Total Liabilities | 511.15B | 488.00B | 392.97B | 351.23B | 307.58B | 293.85B |
| Stockholders Equity | 171.90B | 172.06B | 173.01B | 156.84B | 159.60B | 158.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -61.48B | -1.75B | 9.57B | -16.34B | 19.65B |
| Operating Cash Flow | 0.00 | -23.33B | 9.14B | 19.69B | -7.69B | 30.69B |
| Investing Cash Flow | 0.00 | -23.22B | -6.41B | -11.70B | -11.82B | -12.80B |
| Financing Cash Flow | 0.00 | 43.88B | 6.71B | -6.96B | 1.36B | -3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥2.96T | 17.00 | 14.23% | 2.47% | 2.27% | 70.36% | |
75 Outperform | ¥2.39T | 22.36 | 11.22% | 1.48% | 5.14% | 773.86% | |
74 Outperform | ¥344.14B | 16.73 | 7.62% | 3.44% | 7.54% | 115.47% | |
71 Outperform | ¥3.41T | 19.26 | 13.03% | 1.96% | 10.52% | 71.09% | |
67 Neutral | ¥3.32T | 24.19 | 15.61% | 1.83% | 6.60% | 114.38% | |
64 Neutral | ¥611.63B | 18.33 | 10.95% | 1.88% | 16.67% | 5.82% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |